Lv2
160 积分 2021-09-01 加入
Taming the inflamed heart
1天前
待确认
Mechanistic modeling of FcRn-dependent IgG drug interactions: Clinical applications and dosing implications
2天前
已完结
A phase 1 safety and bioimaging trial of antibody DS-8895a against EphA2 in patients with advanced or metastatic EphA2 positive cancers
25天前
已完结
Epithelial alarmins TSLP, IL-33, and IL-25 in asthma pathogenesis: mechanistic roles and therapeutic implications
25天前
已完结
A Novel Small-Molecule Inhibitor Targeting the IL-6 Receptor β Subunit, Glycoprotein 130
26天前
已完结
Discovery Process of Enlicitide, a Highly Engineered Macrocyclic Peptide Therapeutic, through Issue-Driven Fragment-Based Synthetic Assembly and SAR
29天前
已完结
Development of a 18F-Labeled Bicyclic Peptide Targeting EphA2 for Molecular Imaging of PSMA-Negative Prostate Cancer
1个月前
已完结
Development of a PSMA and EphA2 dual-receptor-activated fluorescent probe for wash-free prostate cancer cell imaging
1个月前
已完结
Clazakizumab for Chronic Active Antibody Mediated Rejection: Lessons from the IMAGINE trial and the Path Forward
1个月前
已关闭
Characterization of anti-CD3 antibodies in clinically available bispecific T cell engagers
1个月前
已完结
皖公网安备34019202002308
